Review





Similar Products

94
MedChemExpress appropriate tet
Appropriate Tet, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tetrandrine/Tetrandrine/pm42303102-77-14-16
Average 94 stars, based on 1 article reviews
appropriate tet - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
MedChemExpress tetrandrine tet
Schematic representation of the TETNPs@Gel in-situ vaccination platform , achieving sustained and potent anti-cancer immune responses through the controlled-release mechanism of TETNPs and HA-DOPA/Mn hydrogels. In-situ gel vaccine encapsulating <t>tetrandrine</t> nanoparticles forms a local reservoir for controlled sustained release of immunotherapeutic agents. This vaccine effectively triggers tumor vascular normalization, activates dendritic cells and effector CD8 + T cells within tumor tissue, thereby inhibiting progression and preventing recurrence in immunologically cold tumors
Tetrandrine Tet, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tetrandrine/Tetrandrine/pmc13383491-25-0-6
Average 94 stars, based on 1 article reviews
tetrandrine tet - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

99
MedChemExpress tetrandrine
Schematic representation of the TETNPs@Gel in-situ vaccination platform , achieving sustained and potent anti-cancer immune responses through the controlled-release mechanism of TETNPs and HA-DOPA/Mn hydrogels. In-situ gel vaccine encapsulating <t>tetrandrine</t> nanoparticles forms a local reservoir for controlled sustained release of immunotherapeutic agents. This vaccine effectively triggers tumor vascular normalization, activates dendritic cells and effector CD8 + T cells within tumor tissue, thereby inhibiting progression and preventing recurrence in immunologically cold tumors
Tetrandrine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tetrandrine/Bafilomycin+A1/pm42046264-42-4-15
Average 99 stars, based on 1 article reviews
tetrandrine - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

86
Shanghai Yuanye Biotechnology tetrandrine 5a
Schematic representation of the TETNPs@Gel in-situ vaccination platform , achieving sustained and potent anti-cancer immune responses through the controlled-release mechanism of TETNPs and HA-DOPA/Mn hydrogels. In-situ gel vaccine encapsulating <t>tetrandrine</t> nanoparticles forms a local reservoir for controlled sustained release of immunotherapeutic agents. This vaccine effectively triggers tumor vascular normalization, activates dendritic cells and effector CD8 + T cells within tumor tissue, thereby inhibiting progression and preventing recurrence in immunologically cold tumors
Tetrandrine 5a, supplied by Shanghai Yuanye Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tetrandrine/5a+tetrandrine/pm41876022-47-32-44
Average 86 stars, based on 1 article reviews
tetrandrine 5a - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

94
TargetMol tetrandrine
Schematic representation of the TETNPs@Gel in-situ vaccination platform , achieving sustained and potent anti-cancer immune responses through the controlled-release mechanism of TETNPs and HA-DOPA/Mn hydrogels. In-situ gel vaccine encapsulating <t>tetrandrine</t> nanoparticles forms a local reservoir for controlled sustained release of immunotherapeutic agents. This vaccine effectively triggers tumor vascular normalization, activates dendritic cells and effector CD8 + T cells within tumor tissue, thereby inhibiting progression and preventing recurrence in immunologically cold tumors
Tetrandrine, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tetrandrine/Tetrandrine/targetmol___t2996
Average 94 stars, based on 1 article reviews
tetrandrine - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

86
Molecular Dynamics Inc tetrandrine
Schematic representation of the TETNPs@Gel in-situ vaccination platform , achieving sustained and potent anti-cancer immune responses through the controlled-release mechanism of TETNPs and HA-DOPA/Mn hydrogels. In-situ gel vaccine encapsulating <t>tetrandrine</t> nanoparticles forms a local reservoir for controlled sustained release of immunotherapeutic agents. This vaccine effectively triggers tumor vascular normalization, activates dendritic cells and effector CD8 + T cells within tumor tissue, thereby inhibiting progression and preventing recurrence in immunologically cold tumors
Tetrandrine, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tetrandrine/tetrandrine/10__1097_slash_md__0000000000045860-13-8-0
Average 86 stars, based on 1 article reviews
tetrandrine - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

93
MedChemExpress isotetrandrine
Schematic representation of the TETNPs@Gel in-situ vaccination platform , achieving sustained and potent anti-cancer immune responses through the controlled-release mechanism of TETNPs and HA-DOPA/Mn hydrogels. In-situ gel vaccine encapsulating <t>tetrandrine</t> nanoparticles forms a local reservoir for controlled sustained release of immunotherapeutic agents. This vaccine effectively triggers tumor vascular normalization, activates dendritic cells and effector CD8 + T cells within tumor tissue, thereby inhibiting progression and preventing recurrence in immunologically cold tumors
Isotetrandrine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tetrandrine/Isotetrandrine/pm41206377-78-13-17
Average 93 stars, based on 1 article reviews
isotetrandrine - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

94
MedChemExpress d tetrandrine
Schematic representation of the TETNPs@Gel in-situ vaccination platform , achieving sustained and potent anti-cancer immune responses through the controlled-release mechanism of TETNPs and HA-DOPA/Mn hydrogels. In-situ gel vaccine encapsulating <t>tetrandrine</t> nanoparticles forms a local reservoir for controlled sustained release of immunotherapeutic agents. This vaccine effectively triggers tumor vascular normalization, activates dendritic cells and effector CD8 + T cells within tumor tissue, thereby inhibiting progression and preventing recurrence in immunologically cold tumors
D Tetrandrine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tetrandrine/Tetrandrine/pmc12490168-50-27-29
Average 94 stars, based on 1 article reviews
d tetrandrine - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


Schematic representation of the TETNPs@Gel in-situ vaccination platform , achieving sustained and potent anti-cancer immune responses through the controlled-release mechanism of TETNPs and HA-DOPA/Mn hydrogels. In-situ gel vaccine encapsulating tetrandrine nanoparticles forms a local reservoir for controlled sustained release of immunotherapeutic agents. This vaccine effectively triggers tumor vascular normalization, activates dendritic cells and effector CD8 + T cells within tumor tissue, thereby inhibiting progression and preventing recurrence in immunologically cold tumors

Journal: Journal of Nanobiotechnology

Article Title: Tetrandrine-based in situ vaccination via multifunctional Mn²⁺-hyaluronic acid hydrogel loading gelatinase-responsive nanoparticles

doi: 10.1186/s12951-026-04545-5

Figure Lengend Snippet: Schematic representation of the TETNPs@Gel in-situ vaccination platform , achieving sustained and potent anti-cancer immune responses through the controlled-release mechanism of TETNPs and HA-DOPA/Mn hydrogels. In-situ gel vaccine encapsulating tetrandrine nanoparticles forms a local reservoir for controlled sustained release of immunotherapeutic agents. This vaccine effectively triggers tumor vascular normalization, activates dendritic cells and effector CD8 + T cells within tumor tissue, thereby inhibiting progression and preventing recurrence in immunologically cold tumors

Article Snippet: Tetrandrine (TET) reagents were purchased from MCE (Shanghai, China).

Techniques: In Situ